LBPH · Categories · Form 4

LBPH - SEC Form 4 insider transactions

Longboard Pharmaceuticals Inc. (LBPH) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for LBPH

• 548d
  SEC Form 4 filed by Director Lynch Casey

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 548d
  SEC Form 4 filed by Director Le Goff Corinne

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 548d
  SEC Form 4 filed by Director Sekhri Paul J

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 548d
  SEC Form 4 filed by Director Schneider Phillip M

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 548d
  SEC Form 4 filed by Director Aurentz Vincent

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 548d
  Executive Vice President & CMO Kaye Randall closing all direct ownership in the company (SEC Form 4)

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 548d
  SEC Form 4 filed by Executive VP and CFO Roberts Brandi

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 548d
  President and CEO Lind Kevin Robert closing all direct ownership in the company (SEC Form 4)

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 561d
  CMO Kaye Randall exercised 30,554 shares at a strike of $6.00, increasing direct ownership by 171% to 48,474 units (SEC Form 4)

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 567d
  CEO Lind Kevin Robert exercised 12,808 shares at a strike of $3.12 and gifted 80,000 shares, decreasing direct ownership by 16% to 363,740 units (SEC Form 4)

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 582d
  SEC Form 4 filed by CMO Kaye Randall

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 582d
  SEC Form 4 filed by CFO Roberts Brandi

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 582d
  SEC Form 4 filed by CEO Lind Kevin Robert

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 595d
  CMO Kaye Randall exercised 16,667 shares at a strike of $4.35 and sold $983,936 worth of shares (16,667 units at $59.03) (SEC Form 4)

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 625d
  CMO Kaye Randall exercised 16,666 shares at a strike of $4.35 and sold $527,318 worth of shares (16,666 units at $31.64) (SEC Form 4)

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 659d
  CEO Lind Kevin Robert exercised 82,482 shares at a strike of $3.15, increasing direct ownership by 24% to 430,932 units (SEC Form 4)

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 740d
  SEC Form 4 filed by Sekhri Paul J

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 740d
  SEC Form 4 filed by Schneider Phillip M

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 740d
  SEC Form 4 filed by Lynch Casey

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 740d
  SEC Form 4 filed by Le Goff Corinne

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 740d
  SEC Form 4 filed by Aurentz Vincent

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 845d
  Kaye Randall was granted 17,920 shares (SEC Form 4)

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 845d
  Roberts Brandi was granted 15,090 shares (SEC Form 4)

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 845d
  SEC Form 4 filed by Lind Kevin Robert

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 856d
  Arena Pharmaceuticals Inc sold $96,479,595 worth of Voting Common Stock (3,978,540 units at $24.25), closing all direct ownership in the company (SEC Form 4)

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 1104d
  SEC Form 4 filed by Sekhri Paul J

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 1104d
  SEC Form 4 filed by Tiller Jane

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 1104d
  SEC Form 4 filed by Aurentz Vincent

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 1104d
  SEC Form 4 filed by Lynch Casey

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 1104d
  SEC Form 4 filed by Schneider Phillip M

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 1104d
  SEC Form 4 filed by Le Goff Corinne

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 1209d
  SEC Form 4 filed by Roberts Brandi

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 1209d
  SEC Form 4 filed by Kaye Randall

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 1209d
  SEC Form 4 filed by Lind Kevin Robert

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 1465d
  SEC Form 4 filed by Tiller Jane

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 1465d
  SEC Form 4 filed by Sekhri Paul J

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 1465d
  SEC Form 4 filed by Schneider Phillip M

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 1465d
  SEC Form 4 filed by Lynch Casey

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 1465d
  SEC Form 4 filed by Le Goff Corinne

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 1465d
  SEC Form 4 filed by Aurentz Vincent

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 1535d
  SEC Form 4 filed by Kaye Randall

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 1573d
  SEC Form 4 filed by Lind Kevin Robert

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 1573d
  SEC Form 4 filed by Roberts Brandi

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 1573d
  SEC Form 4 filed by Perera Philip

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 1660d
  SEC Form 4 filed by Tiller Jane

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)
• 1723d
  SEC Form 4 filed by Aurentz Vincent

  4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)

Other LBPH categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends